BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7153478)

  • 1. Laboratory evaluation of Bacillus thuringiensis var. israelensis serotype H-14 against mosquito larvae with particular reference to Aedes aegypti.
    Sharma SK; Wattal BL; Mathur KK
    J Commun Dis; 1982 Jun; 14(2):106-10. PubMed ID: 7153478
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of two formulations of Bacillus thuringiensis var. israelensis (H-14) against Aedes vexans and safety to non-target macroinvertebrates.
    Gharib AH; Hilsenhoff WL
    J Am Mosq Control Assoc; 1988 Sep; 4(3):252-5. PubMed ID: 3199115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity in carcasses of Bacillus thuringiensis var. israelensis-killed Aedes aegypti larvae against scavenging larvae: implications to bioassay.
    Zaritsky A; Khawaled K
    J Am Mosq Control Assoc; 1986 Dec; 2(4):555-9. PubMed ID: 3507532
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial control of mosquito larvae: investigation of stability of Bacillus thuringiensis var. israelensis and Bacillus sphaericus standard powders.
    Thiery I; Hamon S
    J Am Mosq Control Assoc; 1998 Dec; 14(4):472-6. PubMed ID: 10084145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of larvicidal effects of Bacillus thuringiensis var. israelensis (serotype H-14) and Bacillus sphaericus preparations and the susceptibility of adult mosquitoes to malarial plasmodia].
    Ganushkina LA
    Med Parazitol (Mosk); 1987; (1):10-3. PubMed ID: 3553885
    [No Abstract]   [Full Text] [Related]  

  • 6. Host range and selected factors influencing the mosquito larvicidal activity of the PG-14 isolate of Bacillus thuringiensis var. morrisoni.
    Lacey LA; Lacey CM; Padua LE
    J Am Mosq Control Assoc; 1988 Mar; 4(1):39-43. PubMed ID: 3193097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Mesocyclops thermocyclopoides and Bacillus thuringiensis var. israelensis: a better approach for the control of Aedes aegypti larvae in water containers.
    Chansang UR; Bhumiratana A; Kittayapong P
    J Vector Ecol; 2004 Dec; 29(2):218-26. PubMed ID: 15707281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of Aedes aegypti (L.) strains from Havana to a Bacillus thuringiensis var. israelensis].
    Menéndez Díaz Z; Rodríguez Rodríguez J; Gato Armas R; Companioni Ibañez A; Díaz Pérez M; Bruzón Aguila RY
    Rev Cubana Med Trop; 2012; 64(3):324-9. PubMed ID: 23424808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of slow-release formulations of temephos (Abate) and Bacillus thuringiensis var. israelensis for the control of Aedes aegypti in Puerto Rico.
    Novak RJ; Gubler DJ; Underwood D
    J Am Mosq Control Assoc; 1985 Dec; 1(4):449-53. PubMed ID: 2466106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated management of waste tire mosquitoes utilizing Mesocyclops longisetus (Copepoda: Cyclopidae), Bacillus thuringiensis var. israelensis, Bacillus sphaericus, and methoprene.
    Tietze NS; Hester PG; Shaffer KR; Prescott SJ; Schreiber ET
    J Am Mosq Control Assoc; 1994 Sep; 10(3):363-73. PubMed ID: 7807078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low temperature on feeding rate of Aedes stimulans larvae and efficacy of Bacillus thuringiensis var. israelensis (H-14).
    Walker ED
    J Am Mosq Control Assoc; 1995 Mar; 11(1):107-10. PubMed ID: 7616175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sublethal exposure to Bacillus thuringiensis var. israelensis on larval development and adult size in Aedes aegypti.
    Hare SG; Nasci RS
    J Am Mosq Control Assoc; 1986 Sep; 2(3):325-8. PubMed ID: 3507506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae.
    Seleena P; Lee HL; Lecadet MM
    J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae.
    Thiéry I; Fouque F; Gaven B; Lagneau C
    J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
    Mittal PK; Adak T; Batra CP
    J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of Bacillus thuringiensis H-14 against Aedes aegypti larvae in the northeast region of Thailand.
    Pipitgool V; Maleewong W; Daenseegaew W; Thaiklar K
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):426-8. PubMed ID: 1818396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of granular corncob formulations of Bacillus thuringiensis serovar israelensis against mosquito larvae using a semi-field bioassay method.
    Ali A; Xue RD; Lobinske R; Carandang N
    J Am Mosq Control Assoc; 1994 Dec; 10(4):492-5. PubMed ID: 7707052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of Bacillus thuringiensis subsp. israelensis on Aedes aegypti.
    Ceianu C
    Roum Arch Microbiol Immunol; 1991; 50(1):61-6. PubMed ID: 1802053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inactivation by sunlight on the larvicidal activities of mosquitocidal Bacillus thuringiensis H-14 isolates from Nigerian soils.
    Obeta JA
    J Commun Dis; 1996 Jun; 28(2):94-100. PubMed ID: 8810143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for determining settling rates of Bacillus thuringiensis serotype H-14 formulations.
    Mullen GR; Hinkle NC
    J Am Mosq Control Assoc; 1988 Jun; 4(2):132-7. PubMed ID: 3193109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.